Clinical Trials Directory

Trials / Completed

CompletedNCT02875691

Effect of Green Tea on Treatment of Lupus

The Effect of Green Tea Extract on Some Inflammatory Biomarkers(IL 6, IL1β,TNF α,CRP), Serum Total Antioxidant Capacity(TAC), MDA and Disease Activity in Patients With Systemic Lupus Erythematous

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
68 (actual)
Sponsor
Ahvaz Jundishapur University of Medical Sciences · Academic / Other
Sex
Female
Age
15 Years
Healthy volunteers
Not accepted

Summary

This randomized double blind clinical trial performed on 68 patients (32 in intervention and 36 in control group) diagnosed with SLE. The patients in intervention group were given daily dose of 1000mg of aqueous green tea extract (of 6 gram of dried green tea leaf) in form of two capsules ( 500 mg). Also in control group, the patients were given daily dose of 1000mg of cellulose in form of two capsules ( 500 mg) Variables include SLE disease activity, some biomarkers of inflammation and oxidative stress and anthropometric indicators at baseline and end of the study. The investigators used SLEDAI (systemic lupus erythematous disease activity index ) questionnaire for evaluating the clinical signs of the disease. The questionnaires filled out at baseline and after 3 month.

Detailed description

noting

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTgreen tea extractPatients are given daily dose of 1000mg aqueous green tea extract (of 6 grams of dried green tea leaf) in the form of 2 capsules( 500 mg) for three months.
DIETARY_SUPPLEMENTplaceboPatients in placebo group receive daily dose of 1000 mg cellulose in the form of 2 capsules (500 mg) for three months

Timeline

Start date
2015-09-01
Primary completion
2016-03-01
Completion
2016-03-01
First posted
2016-08-23
Last updated
2016-08-23

Locations

1 site across 1 country: Iran

Source: ClinicalTrials.gov record NCT02875691. Inclusion in this directory is not an endorsement.